ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer
Alec Vaezi1,2, Chelsea H Feldman2, Laura J Niedernhofer2,31Department of Otolaryngology and Head and Neck Surgery, University of Pittsburgh School of Medicine, 2University of Pittsburgh Cancer Institute, 3Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine...
Main Authors: | Vaezi A, Feldman CH, Niedernhofer LJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-07-01
|
Series: | Pharmacogenomics and Personalized Medicine |
Online Access: | http://www.dovepress.com/ercc1-and-xrcc1-as-biomarkers-for-lung-and-head-and-neck-cancer-a7908 |
Similar Items
-
Single Nucleotide Polymorphisms of XRCC1 and the Risk of Head and Neck Cancer
by: VV Narayana Rao, et al.
Published: (2018-08-01) -
ERCC1 and XRCC1 single nucleotide polymorphisms can guide treatment decision in patients with metastatic non-small cell lung cancer
by: Mustafa Karaagac, et al.
Published: (2020-03-01) -
ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma
by: Chen L, et al.
Published: (2016-11-01) -
A Comprehensive Evaluation of the Association between Polymorphisms in XRCC1, ERCC2, and XRCC3 and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis
by: Yan Zhao, et al.
Published: (2019-01-01) -
POLIMORPHISM OF XRCC1, XRCC2, XRCC3 GENES IN LUNG CANCER PATIENTS AND HEALTHY PEOPLE OF KEMEROVO REGION
by: A. V. Ryzhkova, et al.
Published: (2014-09-01)